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INTRODUCTION
Maintenance of excitability of neurons and the axons is the key
for proper neuronal functioning. This fact is easily recognized in
disease conditions that are characterized by abnormal excitability,
such as neuropathic pain, muscle cramps, and paralysis. Indeed,
many factors are associated with its maintenance, namely electro-
lytes, ion channels, and pumps (1).
Ion channels have diverse characteristics. Channels with brief
opening kinetics are important in sudden transmembrane ionic ex-
changes and thus are responsible for generation of an action potential
(e.g., voltage-gated Na+ channels). On the other hand, channels
with slow opening and closing kinetics have little influences on the
generation of action potential. Instead, they are important in setting
a baseline excitability by changing the resting membrane potential
(RMP). If RMP becomes depolarized (e.g., from -70 mV to -65 mV),
the firing threshold becomes closer, so that even smaller trans-
membrane ion exchange can suffice for reaching the threshold to
the generation of an action potential, resulting in extra-discharges
and spontaneous firing.
Ion channels that produce subthreshold conductances are im-
portant in setting the baseline excitability and the following chan-
nels have been recognized in the peripheral axons : (1) slow K+
current (inhibitory), (2) leak current (inhibitory), (3) hyperpolari-
zation-activated cation current (Ih) (excitatory or inhibitory), and
(4) persistent Na+ current (excitatory)(1). To reflect the functional
importance of these currents, pharmacological agents to modify
these currents have shown therapeutic effects on neurological and
other diseases. It is thus important to monitor interval changes of
axonal excitability to achieve intended therapeutic goals by channel -
modifying agents. It is highly possible that compensatory currents
interfere with the intended modification of axonal excitability. Al-
though detailed responses by ion-current modifying agents are
observable in vitro such as patch clamping, the whole in vivo effects
may not be easily assessed by such techniques. Threshold tracking
assesses axonal excitability in vivo, thus a preferred method to
identify interval changes of particular currents/channels by phar-
macological intervention (2).
The aim of the present study was to assess the overall axonal
excitability and potential compensatory mechanisms in a periph-
eral nerve in vivo by pharmacological modification.
METHODS
Study protocol. The experiment was approved by the local
animal facility in Tokushima University. ICR male mice (SLC,
Hamamatsu, Japan), 7 -8 week-old were tested. The following an-
esthetic protocol was used for electrophysiological testing. Isoflu-
rane (2%) was mixed with oxygen (1.5 l/min) for induction in a
plastic box. Within 3 minutes after induction, the mouse became
sedated and was transferred to an exam table where isoflurane
(1.5%) was provided through nasal tube throughout the excitability
testing. The animal was adjusted for 30 minutes before the elec-
trophysiological study was initiated. The body temperature was
maintained above 33 by a thermostat -regulated heatingpad.
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Two medicines were used for inhibition of ion channels : 1) for
K+ channel barium chloride (BaCl2) (Wako, Japan) and 2) for hy-
perpolarization-activated, cyclic nucleotide-gated cation (HCN)
channel ivabradine hydrochloride (Tokyo Chemical Industry,
Japan) were used. For administration of medicines, BaCl2 (9 mM)
was dissolved in distilled water at the concentration of 2 mg/ml.
BaCl2 solution (20 mg/kg) was administered intraperitoneally in
7 male mice. The dosing was determined arbitrarily at the 40% of
the reported LD50 by acute administration of mice (51 mg/kg) (3).
Ivabradine hydrochloride, a selectively inhibiting agent of HCN
channels, was dissolved in water at the concentration of 1 mg/
0.5 ml. The solution of ivabradine (20 mg/kg) was administered
intraperitoneally in 5 male mice, at which level anti -epileptic effect
was reported in mice model (4).
Axonal excitability study. Electrophysiological study setup and
neuronal excitability recording (TRONDNF protocol) were per-
formed as previously explained in detail (5). A set of excitability
parameters was derived from the recordings as previously de-
scribed (6), namely threshold electrotonus (TE) ; the recovery
cycle (RC) ; the current- threshold relationship (I/V) ; the strength-
duration time constant (SDTC). One cycle of the multiple excitabil-
ity tests takes approximately 20 minutes.
The baseline recording of axonal excitability was undertaken
and axonal excitability testing was recorded again 45 minutes post-
injection. For studying a low dose response, a separate study was
performed with dividing the doses of the drugs and provided re-
peatedly as same manner.
Statistical analysis. The axonal excitability testing parameter
changes before and after a single drug concentration was assessed
with a paired t test using SPSS version 20 software (IBM, New York,
USA) where a significance was set at P0.05.
Mathematical modeling. To provide insight into the membrane
parameters underlying changes seen in the effect of an inhibitor,
the Bostock model of the motor axon was used in the simulation
of axonal excitability (MEMFit, QtracP version 01/03/2015), as
previously explained in detail (7 -9). To reflect better the character-
istic waveform changes, the weighting factors were set as follows :
TE, 3 ; RC, 1 ; SDTC, 1 ; and I/V, 3. The following tested parame-
ters were adjusted to minimize the mean error for the simulated
waveforms to best reproduce the average of the recorded wave-
forms : nodal and internodal resting potentials, nodal sodium per-
meability, percent persistent Na+, nodal and internodal slow K+
conductance, nodal and internodal fast K+ conductance, internodal
H conductance, nodal and internodal leak conductance, Barrett -
Barrett conductance, and total pump currents.
RESULTS
Excitability study
Inhibition by BaCl2. A comparison of nerve excitability parame-
ters between at baseline and after administration of BaCl2 was
shown in Figure 1 and Table 1. The following interval changes were
noted :
1) The current- threshold relationship (I/V) (Figure 1, Panel A)
showed a significant reduction of resting slope (P=0.02).
2) In TE (Figure 1, Panel B), greater threshold changes by both
depolarizing and hyperpolarizing currents were present. S2 ac-
commodation that reflects the nodal slow K+ current activity was
decreased at post- injection (P=0.005).
3) RC measurements (Figure 1, Panel C), Refractoriness was
decreased after injection (P=0.03). The superexcitability and late
subexcitability tended to be smaller (P=0.002 and 0.1, respectively).
4) SDTC (Figure 1, Panel D) tended to become slightly smaller
at post- injection (P=0.2).
5) A separate study administering BaCl2 at two divided doses was
performed in a single mouse. A small amount (4 mg/kg) of BaCl2
resulted in the following : (1) decreased threshold reduction by
long hyperpolarization (i.e., downward shift of the waveform) and
slight reduction of late subexcitability and (2) unchanged S2 ac-
commodation. Additional administration of BaCl2 30 minutes apart
(total dosage : 20 mg/kg) resulted in decrease of S2 accommo-
dation and late subexcitability (Figure 2, panels A-B), suggesting
simultaneous effects on slow K+ currents and Ih, instead of specific
effects on slow K+ current, followed by nonspecific action on Ih (see
discussion).
Inhibition by ivabradine. Nerve excitability parameters chang-
ing by ivabradine was illustrated in Figure 3. The following changes
were noted after administration of ivabradine in comparison to
baseline values (Table 2) :
1) The response for the stimulation was increased (P=0.04) after
the administration of ivabradine in the stimulus-current relation-
ship.
2) The current- threshold relationship (I/V) showed smaller
resting I/V slope (P=0.009), but no significant difference with
depolarizing and hyperpolarizing currents.
3) In TE, hyperpolarizing current demonstrated significant
greater threshold change, more so in the initial 40 ms. By strong
hyperpolarization, TEh (peak, -70%) was greater after the drug
administration (P=0.02). S3 accommodation induced by hyperpo-
larizing current increased with ivabradine (P=0.008). Threshold
changes by depolarizing currents became greater by ivabradine,
more so after 40 ms of stimulation.
4) In RC, late subexcitability tended to be smaller after ivabradine.
Otherwise, no interval change was present.
5) SDTC showed no significant change by ivabradine.
6) Similar to BaCl2, a study was performed to administer iv-
abradine at two divided doses in a single mouse. After administer-
ing the low dose (4 mg/kg), there was increase in threshold by
long hyperpolarization (i.e., downward shift) as well as decreased
late subexcitability. The downward shift of the hyperpolarizing TE
was greater after administering the second dose 30 minutes after
the initial injection (total dose : 20 mg/kg)(Figure 2). This sug-
gests simultaneous blockage of Ih and slow K+ current by ivabradine,
instead of specific suppression of Ih followed by nonspecific sup-
pression of slow K+ currents (see discussion).
Modeling. The multiple axonal excitability data for the each group
were averaged and modeled.
BaCl2. Optimized parameters were automatically changed to
minimize the error between the modelled and the observed wave-
forms. By changing single parameter, the post-administration
waveforms were best fit by decreasing the internodal H conduc-
tance (GH), followed by decreasing slow potassium conductances
(GKs), but the degrees of discrepancy reduction was marginal (an
arbitrary goal was80% reduction). In order to achieve better dis-
crepancy reduction, two parameters were adjusted and showed the
best- fit by decreasing GH and GKs (Table 3). Further reduction
was not achieved by increasing the parameters to three.
Ivabradine. Similar to BaCl2, parameters were adjusted automati-
cally to best fit the observed waveforms from the baseline recording.
By 1-parameter scheme, decreasing GH showed the best discrep-
ancy reduction, but the degree was not satisfactory. Thus two
parameters were adjusted. The combination that showed the best
discrepancy reduction was decreasing GH and 10-fold increasing
the pump current, which was practically unrealistic and was re-
jected. The second-best combination was by decreasing GH by
80% and increasing the fast potassium conductances, followed by
decreasing GH and increasing the slow potassium conductances.
Further reduction was not achieved by increasing the parameters
to three. The interval waveform changes by drug administration
were not adequately reproduced by merely decreasing the target
ion currents (Figure 4).
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DISCUSSION
In the present study, we assessed interval changes of sensory
axonal excitability in vivo by administering an ion channel inhibitor
against K+ channels or HCN channels. In addition to the expected
inhibitory effects on the target channels, each inhibitor showed
complex functional changes, suggesting accommodation by other
channels. We assume that this compensatory mechanisms are im-
portant in stabilizing axonal excitability from external changes and
have clinical implications on pharmacotherapy.
Figure 1 : Interval changes of axonal excitability by administration of BaCl2. In comparison to the control waveforms (open circles), the post -
administration waveforms show the following interval changes : (1) similar absolute and relative excitability by stimulus -response curves (Panels
A and B), (2) outward shift of the current - threshold relationship (I/V) by long depolarizing and hyperpolarizing conditioning currents (Panels C
and E), (3) decreased accommodation to long depolarization (S2 accommodation, Panel E) and late subexcitability (Panel F).
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Possible mechanisms for accommodation
In the present study, we administered two drugs that are well
known to be ion channel blockers, BaCl2 on K channels and iv-
abradine on HCN channels (10-12). The similar crystal radius of
Ba2+ compared with K+ and its stronger charge allows Ba2+ to fit
tightly into the deep selectivity filter of K+ channels, acting as K+
channel inhibitor including Kv7, Shaker, and inward rectifier chan-
nels (13, 14). Barium itself has very weak inhibitory function of
HCN channels (15). Ivabradine is a selective inhibitor of HCN
channels, especially on HCN1 subunit and HCN4 (prominently
expressed in the pacemaker region of the myocardium). Neither
of the agents has been reported to act significantly on INaP or
transient Na+ current. The present study demonstrating complex
excitability changes by these drugs, thus suggests altered func-
tions of the channels other than their primary targets.
After administration of barium, there was reduction of Ih and
possibly INaP, along with expected reduction of fast and slow K+
currents. Blockade of IKs causes hyperexcitability, manifesting
as seizure and muscle cramps (16, 17).
On the other hand, ivabradine significantly suppressed Ih as ex-
pected, as well as increase of either fast or slow K+ currents. Al-
though there were contradictory results in Table 4 (decrease of
GKf and GKs by changing one parameter and vice versa by chang-
ing two parameters), the decreases by one-parameter format did
not yield satisfactory discrepancy reduction and thus do not fully
explain the waveform changes. By suppressing excitatory Ih by iv-
abradine, axonal excitability becomes decreased. Ih has a negative-
feedback property ; if hyperpolarizing current is applied, Ih is ac-
tivated and permeability of Na+ increases, resulting in returning
membrane potential toward rest. On the other hand, if depolarizing
current is applied, Ih that is active at rest becomes deactivated,
again returning membrane potential at rest (18). Blocking Ih hy-
perpolarizes the membrane, whereas the input resistance increases
(19), that results in a delicate conductance-current balance. To
summarize, Ih embodies two opposing influences on neuronal ex-
citability and makes simple characterization as either inhibitory or
excitatory to be difficult. It is intriguing that in the central nervous
system, inhibitory action of Ih is caused by its interaction with
delayed rectifier M-type K+ current (20), but we are not aware of
such report in the peripheral nerve. The present data complement
our previous report of acute effects of blocking INaP by ranolazine
(21), that showed features suggestive of suppression of INaP, tran-
sient Na+ current, and slow K+ currents.
Whether resting potential could be affected by either barium or
ivabradine is not straightforward. Excitability parameters that are
sensitive to axonal membrane potentials are the following (22) : (1)
superexcitability, (2) the resting current- threshold slope, (3) de-
polarizing and hyperpolarizing threshold electrotonus at 90-100
ms, and (4) subexcitability. However, 1, 3, and 4 are affected by
either decreasing slow K+ conductance or Ih (Figure 3). Decrease
of the resting current- threshold slope by both barium and iv-
abradine thus suggests hyperpolarizing shift of the resting poten-
tial, but it was not fully supported by other parameters.
Clinical significance
Because neuronal ion channels have been identified as impor-
tant pathophysiological and therapeutic targets in many neurologi-
cal conditions, ion-channel modifying drugs are one of the main
therapies on these conditions. However, monitoring the channel
functions in vivo by the particular drug in the target organ is not
straightforward, especially so in the nervous system. As discussed
above, because fine regulation of neuronal excitability relies on
complex interaction involving multiple ion channels and their
Table 1. Comparison of nerve excitability parameters at the baseline and after administration of BaCl2 (N=7) (meanSEM)
Pre- injection Post - injection P values
Stimulus/current relationship
Stimulus for max response (50%) (mA) 0.30.2 0.30.2 0.8
Peak response (µV) 87.91.2 79.51.2 0.7
Threshold electrotonus
TEd (10-20 ms) 47.80.5 51.10.7 0.002
TEd (40-60 ms) 42.60.8 47.81.3 0.003
TEd (90-100 ms) 41.00.6 47.31.4 0.001
TEh (10-20 ms) -65.92.2 -69.32.2 0.4
TEh (20-40 ms) -74.12.8 -80.42.8 0.2
TEh (90-100 ms) -62.73.2 -75.72.3 0.012
S2 accommodation 6.30.4 3.60.7 0.005
TEh (peak, -70%) -153.54.4 -166.34.4 0.08
S3 accommodation 62.28.2 66.811.1 0.8
Recovery cycle
Refractoriness (2.5 ms) (%) -7.90.8 -12.71.0 0.03
Relative refractory period 1.61.1 1.31.0 0.2
Superexcitability (%) -8.20.4 -13.40.8 0.002
Late subexcitability (%) 2.91.2 0.90.2 0.1
Current/threshold relationship
Resting I/V slope 0.770.03 0.620.05 0.02
Minimum I/V slope 0.630.02 0.520.03 0.005
Hyperpolarizing I/V slope 0.960.13 0.940.10 0.9
Strength-duration time property
Strength-duration time constant 0.230.03 0.190.02 0.2
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modulators, in vivo effect of a channel -modifying agent might not
be identical to observed results in a simpler in vitro system or com-
puter simulation. Threshold tracking is a non- invasive method to
quantify multiple ion channel functions in vivo, thus it has advan-
tage of depicting overall excitability as well as behavior of specific
ion channels in a dynamic manner, certainly in a clinical setting.
This report has implication to therapeutic use of channel -modi-
fying agents in neurological diseases, that is, to possible effects on
multiple, often unexpected, ion channels and overall excitability.
Limitation
This study has limitations. First, the serum concentrations of the
medications were not measured. However, correlation between
the drug concentrations in the serum and the peripheral nerves
may not be linear, thus measurement of serum concentrations
might not directly reflect pharmacological effect in the peripheral
nervous system. Second, suppression of Ih by ivabradine could
have been only partially evaluated because anesthesia by isoflu-
rane also suppresses Ih even at pre-administrative stage (5). It may
partially explain lower discrepancy reduction by the modeling study
by ivabradine (Table 4). Third, modeling study cannot specify re-
sponsible parameters exactly because no single parameter or a
combination of parameters stand out. Another limitation on model-
ing is unrealistic calculation, as seen in Table 4 with 10- fold in-
crease of pump current.
In summary, we underwent in vivo axonal excitability study in
normal mice to identify interval changes of multiple ion channel
functions by administration of specific channel blockers, BaCl2 and
Figure 2 : A separate study administering BaCl2 at two divided doses in a single mouse. A small amount (4 mg/kg) of BaCl2 resulted in the following :
(1) decreased threshold reduction by long hyperpolarization and slight reduction of late subexcitability, but unchanged S2 accommodation.
Additional administration of BaCl2 30 minutes apart (total dosage : 20 mg/kg) resulted in decrease of S2 accommodation and late subexcitability
(Figure 2, panels A-B), suggesting simultaneous effects on slow K+ currents and Ih.
Ivabradine was similarly administered at two divided doses in a single mouse. After administering the low dose (4 mg/kg), there was increase in
threshold by long hyperpolarization as well as decreased late subexcitability. The downward shift of the hyperpolarizing TE was greater after at
the total dose of 20 mg/kg (Figure2, panels C-D). This suggests simultaneous blockage of Ih and slow K+ current by ivabradine.
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Figure 3 : Interval changes of axonal excitability by administration of ivabradine. In comparison to the control waveforms (open circles), the post -
administrationwaveformsshow the following interval changes : (1) similar stimulus -response curves, both by absolute and relative scales (Panels A
and B), (2) outward shift of the current - threshold relationship (I/V) by long hyperpolarizing and depolarizing currents (Panels C and E), (3)
decreasedaccommodation to long depolarization (S2 accommodation, Panel E) and late subexcitability (Panel F). Overall, these changes are similar
to thoseseenbyadministrationofBaCl2 (Figure1).
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ivabradine. The data suggest that modification of functions in other
than the target channels. This information could be useful in plan-
ning ion-channel targeting therapy in neurological diseases.
ABBREVIATIONS
HCN channel, hyperpolarization-activated cyclic nucleotide-
gated channel
Ih, hyperpolarization-activated cation current
IKs, slow K+ current
INaP, persistent Na+ current
IV, current- threshold relationship
RC, recovery cycle
SDTC, strength-duration time constant
TE, threshold electrotonus.
Table2. Comparison of nerve excitability parameters at the baseline and after administration of ivabradine (N=5) (meanSEM)
Pre- injection Post - injection P values
Stimulus/current relationship
Stimulus for max response (50%) (mA) 0.320.15 0.340.16 0.04
Peak response (µV) 98.01.3 81.21.3 0.003
Threshold electrotonus
TEd (10-20 ms) 45.61.7 48.21.3 0.09
TEd (40-60 ms) 41.01.0 45.50.9 0.01
TEd (90-100 ms) 40.91.1 45.10.8 0.008
TEh (10-20 ms) -58.31.7 -67.12.6 0.004
TEh (20-40 ms) -62.43.7 -77.23.6 0.001
TEh (90-100 ms) -57.93.6 -73.35.4 0.055
S2 accommodation 4.61.0 3.11.1 0.3
TEh (peak, -70%) -137.79.2 -162.06.9 0.02
S3 accommodation 57.213.7 68.011.7 0.008
Recovery cycle
Refractoriness (2.5 ms) (%) -5.12.6 -5.22.2 0.9
Relative refractory period 1.71.1 1.91.1 0.6
Superexcitability (%) -5.02.0 -8.01.33 0.2
Late subexcitability (%) 2.10.2 1.10.4 0.13
Current/threshold relationship
Resting I/V slope 0.850.07 0.660.07 0.009
Minimum I/V slope 0.680.04 0.490.09 0.1
Hyperpolarizing I/V slope 1.190.22 0.770.17 0.2
Strength-duration time property
Strength-duration time constant 0.220.03 0.250.05 0.4
Table 3 :Modeling the nerve excitability data from animals post -administration of BaCl2 (discrepancy reduction from pre-administration wave-
forms/parameter settings)
Parameter change discrepancy reduction
1 GH -66% 77.9%
2 GKs -87% 73.7%
3 GKf -86% 54.6%
4 GBB +38% 43.2%
5 GLk -41% 40.7%
Parameter 1 change Parameter 2 change discrepancy reduction
1 GH -52% GKs -40% 82.4%
2 PNap (%) -46% GH -66% 79.2%
3 GKs -77% GLk -18% 78.8%
4 GH -64% GKf -2% 78.6%
5 GBB +13% GKs -86% 78.5%
GBB= ‘Barrett -Barrett’ conductance across myelin sheath ; GH=internodal H conductance ; GKs=nodal and internodal slow potassium conduc-
tances ; GLk=nodal and internodal leak conductances ; PNap=persistent sodium conductance (as% of nodal sodium permeability)













Figure 4 : Modeled waveform changes by altering 1 parameter. (1) By arbitrarily decreasing the nodal slow K+ conductance (GKsN) to 25% of nor-
mal, accommodation to long depolarizing current is lost (Panels A and B) and there are decreased late subexcitability and increased supernormality
(Panel C). (2) By arbitrarily decreasing the internodal H conductance (GH) to 50% of normal, there are increased threshold changes to hyperpolariz-
ing current (Panels E and F) and decreased late subexcitability and increased supernormality (Panel G). Of note, accommodation to depolarizing
current was unchanged (arrow, Panel E). These changes do not reproduce the waveforms by administering BaCl2 or ivabradine (Figures 1-2),
suggesting alteration of multiple ion channel properties by the respective compounds.
The Journal of Medical Investigation Vol. 64 February 2017 37
CONFLICT OF INTEREST STATEMENT
None of the authors has conflict of interest.
FUNDING
This work was supported by Grants- in-Aid from the Intramural
Research Grant (25-4) for Neurological and Psychiatric Disorders
of NCNP, Japan.
REFERENCES
1. Krishnan AV, Lin CS, Park SB, Kiernan MC : Axonal ion chan-
nels from bench to bedside : a translational neuroscience per-
spective. Prog Neurobiol 89 : 288-313, 2009
2. Bostock H, Cikurel K, Burke D : Threshold tracking tech-
niques in the study of human peripheral nerve. Muscle Nerve
21 : 137-58, 1998
3. ProChemOnline.com. Safety Data Sheet : Barium Chloride,
Dihydrate. 2014.
4. Luszczki JJ, Prystupa A, Andres-Mach M, Marzeda E, Florek-
Luszczki M : Ivabradine (a hyperpolarization activated cyclic
nucleotide-gated channel blocker) elevates the threshold for
maximal electroshock- induced tonic seizures in mice. Phar-
macol Rep 65 : 1407-14, 2013
5. Osaki Y, Nodera H, Banzrai C, Endo S, Takayasu H, Mori A,
Shimatani Y, Kaji R : Effects of anesthetic agents on in vivo
axonal HCN current in normal mice. Clin Neurophysiol, 2015
6. Shibuta Y, Shimatani Y, Nodera H, Izumi Y, Kaji R : Increased
variability of axonal excitability in amyotrophic lateral sclero-
sis. ClinNeurophysiol124 : 2046-53,2013
7. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H : Acute
tetrodotoxin- induced neurotoxicity after ingestion of puffer
fish. Ann Neurol 57 : 339-48, 2005
8. Trevillion L, Howells J, Bostock H, Burke D : Properties of low-
threshold motor axons in the human median nerve. J Physiol
588 : 2503-15, 2010
9. Howells J, Trevillion L, Bostock H, Burke D : The voltage
dependence of I(h) in human myelinated axons. J Physiol
590 : 1625-40, 2012
10. Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco
D : Properties of ivabradine- induced block of HCN1 and
HCN4 pacemaker channels. J Physiol 572 : 335-46, 2006
11. Gibor G, Yakubovich D, Peretz A, Attali B : External barium
affects the gating of KCNQ1 potassium channels and pro-
duces a pore block via two discrete sites. J Gen Physiol 124 : 83-
102, 2004
12. Armstrong CM, Swenson RP, Jr., Taylor SR : Block of squid
axon K channels by internally and externally applied barium
ions. J Gen Physiol 80 : 663-82, 1982
13. Jiang Y, MacKinnon R : The barium site in a potassium chan-
nel by x-ray crystallography. J Gen Physiol 115 : 269-72, 2000
14. Hurst RS, Latorre R, Toro L, Stefani E : External barium block
of Shaker potassium channels : evidence for two binding sites.
J Gen Physiol 106 : 1069-87, 1995
15. Macri V, Angoli D, Accili EA : Architecture of the HCN se-
lectivity filter and control of cation permeation. Sci Rep 2 : 894,
2012
16. Schwarz J, Glassmeier G, Cooper E, Kao T, Nodera H, Tabuena
D, Kaji R, Bostock H : KCNQ channels mediate IKs, a slow K+
current regulating excitability in the rat node of Ranvier. J
Physiol 573 : 17-34, 2006
17. Maljevic S, Wuttke TV, Seebohm G, Lerche H : KV7 channelo-
pathies. Pflugers Arch 460 : 277-88, 2010
18. Cervetto L, Demontis GC, Gargini C : Cellular mechanisms
underlying the pharmacological induction of phosphenes. Br
J Pharmacol 150 : 383-90, 2007
19. Mishra P, Narayanan R : High-conductance states and A-type
K+ channels are potential regulators of the conductance-
current balance triggered by HCN channels. J Neurophysiol
113 : 23-43, 2015
20. George MS, Abbott LF, Siegelbaum SA : HCN hyperpolariza-
tion-activated cation channels inhibit EPSPs by interactions
with M-type K(+) channels. Nat Neurosci 12 : 577-84, 2009
21. Nodera H, Rutkove SB : Changes of the peripheral nerve ex-
citability in vivo induced by the persistent Na+ current blocker
ranolazine. Neurosci Lett 518 : 36-40, 2012
22. Kiernan M, Bostock H : Effects of membrane polarization and
ischaemia on the excitability properties of human motor ax-
ons. Brain 123 Pt 12 : 2542-51, 2000
Table 4 :Modeling of the nerve excitability data from animals post -administration of ivabradine (discrepancy reduction from pre-administration
waveforms)
Parameter change discrepancy reduction
1 GH -58% 63.0%
2 GKf -71% 44.6%
3 GKs -99% 41.5%
4 PNap +4800% 36.6%
5 PNaN +327% 35.2%
Parameter 1 change Parameter 2 change discrepancy reduction
1 GH -77% IPumpNI +1000% 81.5%
2 GH -82% GKf +244% 73.9%
3 GH -83% GKs +228% 68.3%
4 PNaN -41% GH -71% 67.5%
5 GH -53% GBB +29% 65.6%
GBB= ‘Barrett -Barrett’ conductance across myelin sheath ; GH=internodal H conductance ; GKf=nodal and internodal fast potassium conduc-
tances ; GKs=nodal and internodal slow potassium conductances ; GLk=nodal and internodal leak conductances ; PNaN=nodal sodium permeabil-
ity ; PNap=persistent sodium conductance (as% of nodal sodium permeability)
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